The week ahead – week 18

  • The American Association of Clinical Endocrinologists (AACE) holds its Annual Meeting in Austin
  • Geneva hosts the European Lung Cancer Conference (ELCC)
  • The Pediatric Academic Societies organise an Annual Meeting in San Francisco
  • The Association for Research in Vision and Ophthalmology has its Annual Meeting in Baltimore
  • Neurocrine starts its full commercial launch of Ingrezza which was recently approved in tardive dyskinesia
  • Celgence presents data from its Phase II PACE in treating anaemia in patients with myelodysplastic syndromes at the International Symposium on Myelodysplastic Syndromes
  • Swiss based Cosmo Pharma launches Eleview, its Methylene Blue based stain for better detection of lesions in endoscopy
  • TherapeuticsMD has a PDUFA date of NDA for its estradiol softgel capsule
  • Bristol-Myers Squibb presents Phase III data of CheckMate-143 as monotherapy versus Avastin in glioblastoma
  • Gilead presents data from its Phase II FITZROY trial in Crohn’s disease

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s